Abstract:Abstract Background The adverse reactions (ADRs) of targeted therapy were closely associated with treatment response, clinical outcome, quality of life (QoL) of patients with cancer. However, few studies presented the correlation between ADRs of targeted therapy and treatment effects among cancer patients. This study was to explore the characteristics of ADRs with targeted therapy and the prognosis of cancer patients based on the clinical data. Methods A retrospective secondary data analysis was conducted within an ADR data set including 2703 patients with targeted therapy from three Henan medical centers of China between January 2018 and December 2019. The significance was evaluated with chi-square test between groups with or without ADRs. Univariate and multivariate logistic regression with backward stepwise method were applied to assess the difference of pathological characteristics in patients with cancer. Using the univariate Cox regression method, the actuarial probability of overall survival was performed to compare the clinical outcomes between these two groups. Results A total of 485 patients were enrolled in this study. Of all patients, 61.0% ( n = 296) occurred ADRs including skin damage, fatigue, mucosal damage, hypertension and gastrointestinal discomfort as the top 5 complications during the target therapy. And 62.1% of ADRs were mild to moderate, more than half of the ADRs occurred within one month, 68.6% ADRs lasted more than one month. Older patients ( P = 0.022) and patients with lower education level ( P = 0.036), more than 2 comorbidities ( P = 0.021), longer medication time ( P = 0.022), drug combination ( P = 0.033) and intravenous administration ( P = 0.019) were more likely to have ADRs. Those with ADRs were more likely to stop taking ( P = 0.000), change ( P = 0.000), adjust ( P = 0.000), or not take the medicine on time ( P = 0.000). The number of patients with recurrence ( P = 0.000) and metastasis ( P = 0.006) were statistically significant difference between ADRs and non-ADRs group. And the patients were significantly poor prognosis in ADRs groups compared with non-ADRs group. Conclusion The high incidence of ADRs would affect the treatment and prognosis of patients with cancer. We should pay more attention to these ADRs and develop effective management strategies.

Clinical analysis of 1946 cases of adverse drug reactions associated with chemotherapy in cancer patients

Clinical analysis of 273 adverse drug reaction reports of antineoplastics in our hospital

Analysis of 281 Adverse Drug Reaction Reports of Antineoplastics Drugs in Our Hospital

Adverse reactions of targeted therapy in cancer patients: a retrospective study of hospital medical data in China

Analysis of 422 cases adverse drug reactions of antineoplastic drugs

Characteristics of Adverse Reactions of Antineoplastic Drugs in 787 Cases and the Prognosis Analysis

Analysis of 56 Adverse Drug Reaction Cases Induced by Oxaliplatin in Our Hospital

Analysis on adverse reactions induced by paclitaxel in treatment of breast cancer in Peking University Cancer Hospital from 2014 to 2016

Anticancer therapy-induced adverse drug reactions in children and preventive and control measures

2008-2011 Adverse Drug Reaction Analysis of 490 Cases in Huadong Hospital

Analysis of 145 ADR Reports of Children in Our Hospital in 2010

Analysis on 342 Repors and Discssion about the Methods of Prevention with Adverse Drug Reactions/events

Clinical analysis of severe adverse drug reactions in Peking Union Hospital from 2013 to 2015

Analysis of 136 ADRs Induced by Chinese Patent Medicine

Analysis of the Adverse Drug Reactions Reports of 139 Cases

Evaluation of adverse drug reactions of chemotherapeutic agents used in advanced non-small cell lung cancer – experience from a rural tertiary care institution in North Eastern India

Adverse reactions associated with nivolumab and small molecule antiangiogenic drugs: A pharmacovigilance analysis

Analysis on Adverse Drug Reactions in Our Hospital from 2008 to 2010

Influence factors of chemotherapy toxicities in breast cancer patients

Analysis of Adverse Drug Reactions in 468 Cases

Prevention and Treatment Adverse Drug Reactions of Antitumor Medicines